Brian Birk

Chairman of the Board

Brian Birk has served as a member of our board of directors since June 2008. In 2006, Mr. Birk co-founded Sun Mountain Capital, a boutique private equity firm focused... on the Southwest and Rocky Mountain regions which currently manages direct investment funds and funds of funds vehicles. Prior to forming Sun Mountain Capital, Mr. Birk was a Vice President and Director of Private Equity at Fort Washington Capital Partners, a professional investment management services company. Mr. Birk was also a senior executive at MetaWeb Technologies, Inc., a technology and web development company acquired by Google Inc. in 2010, the vice president of technology commercialization at Applied Minds, LLC, a technology consulting company, and the president of a division at BiosGroup Inc., a company which commercialized complex science software. In addition, Mr. Birk held a senior manager position at the Boston Consulting Group, Inc., a global management consulting firm, and finance manager positions at General Electric Company and GE Capital Corporation. Mr. Birk is currently a member of the board of directors of several private companies, including Aspen Avionics, Inc., an aircraft avionics manufacturer, and American Clay Enterprises, LLC, a plaster manufacturing and sales company. Mr. Birk received a B.S. in Economics from Carleton College and an M.B.A. from Northwestern University's Kellogg School of Management.

Open Close

Ebetuel (Beto) Pallares, Ph.D

Ebetuel Pallares, Ph.D. has served as a member of our board of directors since October 2012. Dr. Pallares founded Joseph Advisory Services, LLC, a strategic consulting... firm, in 2006, and has served as its manager since that time. In June 2009, he co-founded Cottonwood Capital Partners, the general partner of Cottonwood Technology Fund, a seed and early-stage venture fund with headquarters in El Paso, Texas, and he has served as its managing partner since that time. Dr. Pallares also serves on several corporate and non-profit boards, as an advisor to the UT Horizon Fund, the venture capital investment fund of the University of Texas system, as an Investor in Residence for New Mexico State University's Arrowhead Center and on the limited partnership advisory committee for several venture funds. He received a B.A. in economics from Brandeis University, an M.B.A. from The University of Texas at El Paso, or UTEP, and a Ph.D. in International Business from UTEP.

Open Close

Ron Rocca

President & CEO, Exagen Diagnostics, Inc.

Fortunato Ron Rocca has served as our President and Chief Executive Officer since October 2011 and as a member of our board of directors since December 2011. From 2005... to October 2011, Mr. Rocca served as Vice President, Sales and Marketing, and as General Manager, at Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company which was acquired by Nestlé© SA in 2011, where he was responsible for leading the commercial organization, strategic planning and implementing projects designed to maximize brand sales. Prior to Prometheus, Mr. Rocca was the General Manager of Alpharma Inc., a specialty pharmaceutical company. Earlier in his career, Mr. Rocca served in senior sales and marketing management positions for Elan Pharmaceuticals, Inc., a neuroscience-focused biotechnology company. Mr. Rocca received a B.A. in Marketing and Personnel Management from Towson University.

Open Close

James L.L. Tullis

Founder & CEO, Tullis Health Investors

Jim Tullis founded Tullis Health Investors ("THI" or "Tullis-Dickerson & Co., Inc.") in 1986 and has a career of over 40 years in health care investing.Prior to... establishing Tullis Health Investors, Jim was a Senior Vice President of E.F. Hutton & Co. (1983-1986) and a Principal at Morgan Stanley & Co. (1974-1983), where he led health care investment research and, later, healthcare investment banking. During his tenure at Morgan Stanley, he received recognition fourteen times on the Institutional Investor All-Star list of Wall Street's top securities analysts and listing as a top home run hitter. He was twice named #1 Drug Analyst and was featured on the Wall Street Week television program. From 1972-1974, Jim was Vice President of Putnam Funds researching health care industry equities. Under Jim's direction, THI has managed several venture capital funds investing into the health care industry. Winning portfolio companies of those funds include Adams Respiratory and Sirion (with innovative concepts in pharmaceuticals); Synageva and BioRexis (biotechnology); Atritech and Vidacare (medical devices); PSS World Medical and Impulse Monitoring (medical services); and Intelliclaim and QuadraMed (health care information technology).Jim is a graduate of Stanford University and earned an MBA from Harvard Business School. He currently sits on the Boards of the Lord Abbett family of mutual funds, Alphatec Holdings (NASDAQ: ATEC), Crane Corporation (NYSE: CR), LivHOME, Inc., SupplyPro, Inc., Exagen Diagnostics, Inc., electroCore, LLC, and SafeOp Surgical, Inc.

Open Close

Arthur Weinstein M.D. MACR, FRCP

Arthur Weinstein, M.D. has served as a member of our board of directors since December 2013 and our Chief Medical Officer since October 2017. Dr. Weinstein has a long... academic career with a clinical and research focus on Systemic Lupus Erythematosus and other Autoimmune Rheumatic Diseases. Currently, he is Professor Emeritus of Medicine at Georgetown University and has served as Professor since 2002. In addition, Dr Weinstein is Emeritus Chief of Rheumatology, Associate Chair of the Department of Medicine at the Medstar Washington Hospital Center in D.C. He has served in leadership roles on the Board of Directors for the Lupus Foundation of America's D.C./ Maryland/ Virginia Chapter since 2002. Dr. Weinstein was elected Fellow of the Royal College of Physicians (UK) in 2011, and was recognized as Master (2009) and received a Distinguished Service Award (2015) by the American College of Rheumatology. Dr. Weinstein received an M.D. from the University of Toronto, and completed his residency and fellowship training in Internal Medicine and Rheumatology at the University of Toronto and University of London (UK).

Open Close

Daniel Cosgrove Burrell

Daniel C. Burrell has served as a member of our board of directors since October 2017. In 2002 Mr. Burrell served the Clinton Administration and also Directed West... Coast Finance with John Kerry for President until its conclusion in 2004. Mr. Burrell has extensive successful leadership experience in Finance and Real Estate including the formation of Rosemont Capital which oversaw over $400mm in assets and subsequently serving as CEO of Rosemeont Realty from 2008 until 2013, continuing on the company’s Board for several years thereafter.
In 2014, Mr. Burrell served as Founder, Executive Chairman, and CEO of The Burrell College of Osteopathic Medicine (BCOM), the nation’s first independently accredited, privately financed, university affiliated college of medicine in the United States. Located in New Mexico, BCOM’s mission is to address chronic doctor shortages in rural and underserved areas and a second medical school is underway in Idaho.
As an active leader and philanthropist, Mr. Burrell is Chairman and CEO of The Burrell Group, Co- Chairman and CEO of CryptoWatt, Managing Director and Principal of BG Life Sciences and Technology Fund, and Founder and Chairman of the New Mexico Leadership Institute and The Burrell Centers for Health Policy and Research.
Mr. Burrell received a Bachelor’s of Arts and Sciences degree from Georgetown University, a J.D. from Yale University, and a General Course Degree from the London School of Economics. He lives in Aspen, Colorado.

Open Close

Pin It on Pinterest

Share This